|
    ABT U.S.: NYSE

    Abbott Laboratories

    ABTUS
    After Hours
    Last Updated: Oct 27, 2021 5:34 p.m. EDT Delayed quote

    $ 127.70

    -0.01 -0.01%
    After Hours Volume: 95.92K
    Close Chg Chg %
    $127.71 -0.42 -0.33%
    Advanced Charting
    Volume: 4.13M 65 Day Avg: 4.56M
    91% vs Avg
    127.37 Day Range 129.40
    103.13 52 Week Range 129.70

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABT Overview

    Performance

    5 Day
    • 3.57%
    1 Month
    • 6.91%
    3 Month
    • 5.97%
    YTD
    • 16.64%
    1 Year
    • 20.01%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 25 Full Ratings

    Recent News

    Read full story

    Abbott Laboratories stock outperforms competitors despite losses on the day

    Read full story

    Abbott Laboratories stock rises Tuesday, outperforms market

    Read full story

    Abbott Laboratories stock falls Monday, underperforms market

    Read full story

    Abbott Laboratories stock outperforms market on strong trading day

    Read full story

    Abbott Laboratories stock outperforms competitors on strong trading day

    Read full story

    The S&P 500 Makes a Comeback. The Funk Is Coming to an End.

    Read full story

    Abbott Laboratories stock outperforms market on strong trading day

    Read full story

    Abbott Labs Earnings Beat Estimates. Its Stock Is Rising.

    Abbott Raises Full-Year Earnings Guidance

    Abbott Laboratories stock surges after big profit and sales beats, and upbeat full-year outlook

    Abbott Labs 3Q Earnings Rise as Covid-19 Testing Lifts Diagnostics Business

    Abbott Laboratories sees 2021 adj. EPS $5.00-$5.10; FactSet consensus $4.46

    Abbott Laboratories Q3 sales $10.93 bln vs. $8.85 bln a year ago; FactSet consensus $9.56 bln

    Abbott Laboratories Q3 adj. EPS $1.40; FactSet consensus 94 cents

    Abbott Laboratories Q3 EPS $1.17 vs. 69 cents a year ago

    Read full story

    Abbott Laboratories stock outperforms market on strong trading day

    Abbott Labs Expected to Post 3Q Sales Growth -- Earnings Preview

    Read full story

    Abbott Laboratories stock outperforms competitors despite losses on the day

    Enzo Biochem Names Hamid Erfanian as Chief Executive

    Read full story

    Paid Family Leave is Still in Biden’s Build Back Better Plan, Buttigieg Says

    Private Wealth Group, LLC Buys iShares MSCI Emerging Markets ETF, Vanguard Financials ETF, SPDR ...

    on GuruFocus.com

    Earnings Estimates Rising for Abbott (ABT): Will It Gain?

    on Zacks.com

    Thermo Fisher (TMO) Beats on Q3 Earnings, Raises 2021 View

    on Zacks.com

    Boston Scientific (BSX) Q3 Earnings Top Estimates, Margins Up

    on Zacks.com

    Masimo's (MASI) Q3 Earnings Surpass Estimates, '21 View Up

    on Zacks.com

    Wednesday’s Top Analyst Upgrades and Downgrades: Abbott Labs, Alphabet, Cloudflare, DraftKings, Microsoft, UPS and More

    on 247WallSt.com

    AbbVie Takes Another Step Toward Its Post-Humira Future

    on Motley Fool

    First Business Financial Services, Inc. Buys Amazon. ...

    on GuruFocus.com

    Montis Financial, LLC Buys iShares Core Dividend Growth ETF, General Dynamics Corp, Sells ...

    on GuruFocus.com

    Ecolab (ECL) Q3 Earnings & Revenues Beat Mark, Margins Down

    on Zacks.com

    Has Abbott Laboratories (ABT) Outpaced Other Medical Stocks This Year?

    on Zacks.com

    Got $5,000? These 2 Unstoppable Stocks Are No-Brainer Buys

    on Motley Fool

    JJJ Advisors Inc. Buys First Trust TCW Unconstrained Plus Bond ETF, GLOBAL X FDS, Berkshire ...

    on GuruFocus.com

    Abbott's (ABT) Organic Sales Grow Amid Spike in COVID Cases

    on Zacks.com

    What Could These Clinical Results Mean for AbbVie's Shareholders?

    on Motley Fool

    Why Senseonics Holdings Stock Popped This Week

    on Motley Fool

    Wall Street Analysts Are Bullish on Top Healthcare Picks

    on TipRanks.com

    Stock Market News for Oct 21, 2021

    on Zacks.com

    Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Biogen (BIIB) and Radius Health (RDUS)

    on TipRanks.com

    3 Things Investors Should Love About Abbott's Q3 Results

    on Motley Fool

    Abbott Laboratories

    Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson -1.21% $436.33B
    Roche Holding AG -0.95% CHF311.39B
    Roche Holding AG Akt -0.87% CHF311.39B
    Novo Nordisk A/S Series B -0.79% kr.1.56T
    Pfizer Inc. -1.35% $244.23B
    Merck & Co. Inc. -0.86% $208.21B
    AstraZeneca PLC -0.10% £139.47B
    AstraZeneca PLC ADR 0.84% $192.34B
    Medtronic PLC -1.25% $166.95B
    Siemens AG -0.47% €112.96B
    Competitor Data Provided ByCapital Cube Logo